EGFR and cancer: The binding characteristics of selected G. glabra bioactive compounds (i.e., LTS0058805, LTS0114552, LTS0128805, LTS0174203,LTS0007447, and LTS0164690) concerning EGFR, have been thoroughly documented and merit further exploration for their potentialapplication in cancer management.